Teva Pharmaceuticals Europe: Patients Search for Information Online – but Aren’t Sure If They Can Trust What They Find
Recent research commissioned1 by Teva Pharmaceuticals has shown that patients, especially those with chronic conditions, have a significant need for online information but they question the reliability of some sources.1
Today, Teva in Europe announced a series of partnerships and initiatives aimed at directly addressing this unmet need. The first, a partnership with Healint, the developer of the Migraine Buddy© platform, will provide real-world evidence about the many issues and outcomes experienced by migraine patients in Europe. These statistical insights produced by Healint on their platform are based on the contributions of patients, who opt-in to share about their condition anonymously for the purpose of increased migraine awareness, and research. This patient-reported evidence with an unprecedented scale will support the generation of educational and supportive content for doctors, neurologists, health specialists and individuals looking to enhance their understanding of migraine.
Recent research in the professional field highlights the growing interest by medical professionals in digital assets to support their continuous education needs and day-to-day work. A 2017 DRG Digital report found that millennial physicians are more reliant on digital sources of information spending as much as three hours consulting external digital resources including websites for healthcare professionals. They source online medical journals and medical reference sites far more frequently than their older peers.2
To address this professional need Teva is working with Migraine Trust International Symposium (MTIS) to create engaging online interviews with leaders in the field of neurology including Professor of Neurology at King's College London and Medical Trustee of The Migraine Trust, Peter J. Goadsby on the subject of ‘Recent advances in headache neuroimaging’. These videos and content will be made available through the MTIS website for UK delegates and on NeurologyBytes.com for non-UK delegates.
Neurology Bytes is a European Healthcare Professional portal initiated by Teva Europe that hosts a variety of educational content that complements the busy schedule of a neurologist and addresses the unmet need for reliable and trustworthy information.
CEO and Co-Founder of Healint, Francois Cadiou commends Teva’s efforts to provide independently reviewed information to support healthcare professionals in becoming more knowledgeable about migraine. “Our collaboration with Teva aims to support healthcare professionals to understand migraine patients better, so that they can obtain the most effective care plan faster. We at Healint are happy to support this transformative initiative with the unique data analysis carried out on the Healint platform. This fact-based information and our collaboration with Teva provides significant benefits to the entire migraine community.”
Professor of Neurology at King's College London and Medical Trustee of The Migraine Trust, Peter J. Goadsby MD PhD stated: “Migraine is a complex condition which requires broader disease awareness in order for patients to communicate effectively about their condition. Patients often need to be their own advocates given the significant amount of patient information doctors require to diagnose and treat their conditions. I welcome Teva’s initiatives which aim to support both the patient and the medical community through reliable and trustworthy information. I hope this initiative creates a better dialogue between patients and their doctors so they can determine the best course of treatment for this debilitating condition.”
Teva Head of Digital, Timothy White said: “Teva is committed to empowering patients and professionals around the world through their health journey, especially those living with or treating chronic conditions such as migraine, by providing high quality medicines as well as tools based on human insights. Our partnerships with MTIS and Healint as well as the growth of our Neurologybytes.com platform demonstrate the practical ways of how we are bringing the vision to life.”
About the Research
The research (2018) found:
- 7 in 10 people (73%) in the UK have a chronic condition and online resources continue to be sought with over half (58%) of UK respondents with chronic conditions claiming to have searched for information on a weekly or monthly basis1
- People living with chronic conditions were more likely to search for health information online on a weekly or monthly basis (58%) compared to those without chronic conditions (44%)1
- The biggest issue that the UK faces in relation to online health information is understanding if it is trustworthy and reliable1
- Search engines are the most popular online source of health information but not the most trusted. For example, in the UK, the NHS Choices website is the most trusted source of information with 3 out of 4 (75%) of respondents stating they trust the site to have quality and dependable information1
Migraine is an unpredictable neurological condition with symptoms such as severe head pain and physical impairment that can impact quality of life and productivity.3 There are two clinical manifestations of migraine – chronic, where patients suffer 15 or more headache days per month, and episodic, where patients have 14 or less headache days per month.4 With more than 1 billion people affected worldwide, migraine is the third most prevalent illness in the world.3
1. Edelman Intelligence 2018. Teva Brand Research - UK information
2. Meet the Millennial Physicians – Young, Mobile, and Harder to Reach. DRG Digital. Available at: https://www.drgdigital.com/drg-digital-innovation-blog/meet-the-millennial-physicians-young-mobile-and-harder-to-reach. Accessed 31.08.18
3. Migraine Research Foundation, Migraine Facts. Available at: http://migraineresearchfoundation.org/about-migraine/migraine-facts/. Accessed 31.08.18
4. Adapted from American Migraine Foundation. Available at: https://americanmigrainefoundation.org/understanding-migraine/chronic-migraine/. Accessed 31.08.18
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. We deliver high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs. We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated R&D function, strong operational base and global infrastructure and scale. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 45,000 professionals, committed to improving the lives of millions of patients. Learn more at www.tevapharm.com.
Healint helps the one billion people who suffer from migraine and other neurological conditions and is the developer of the world’s largest migraine tracking and research platform Migraine Buddy©. With more than one million registered users and 100 million migraine days tracked on the platform, Migraine Buddy© is the most popular condition-specific app in the world, and a Top 10 medical app in the USA and Europe. Using deep analytics and machine learning, Healint generates real-world evidence for patients, physicians, and researchers to improve treatment outcomes and expedite clinical trials. Healint collaborates with the world's leading scientists to improve the diagnosis, treatment, and lives of patients suffering from multiple neurological conditions. For more information, visit: www.healint.com.
Date of Preparation: September 2018 | Ref: UK/CPE/18/0065
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
BolySolar Announcing Launch of BolySolar Tree24.9.2018 11:00 | Pressemelding
Bolymedia Holdings Co. Ltd., a global high-tech company headquartered in Silicon Valley, is pleased to announce its fifth patented renewable energy product – BolySolar Tree - at the Anaheim, California SPI to be held on September 24-27, 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005050/en/ BolySolar Tree (Graphic: Business Wire) BolySolar is a complete set of solar technologies and products that will revolutionize the entire energy industry. At SPI this month, the company will be showcasing its fifth product from its growing line of solar technologies - the BolySolar Tree. The diagram shows the basic design of the BolySolar Tree. The basic idea of the BolySolar Tree is to allow double-sided solar energy utilization with the help of mirrors, thereby reducing solar energy system costs and generating electricity for a longer duration. Compared to the conventional fixed-mount PV panel systems or tracker-mounted P
The 9th Edition of Tour of China 2018 Comes to an End24.9.2018 10:45 | Pressemelding
The sixteen-day Tour of China 2018 is concluded in Anshun, Guizhou Province on 23rd September, as the 13th stage witnesses the victory of Jakub Mareczko from Wilier Triestina – Selle Italia. The last stage in Anshun is a circuit race of 127.8 kilometers with two sprints and one KOM of Category 4. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005421/en/ The riders are crossing the finishing line. (Photo: Business Wire) The stage remained exciting and unpredictable due to little difference between riders’ results after the 12th stage. No rabbit group was formed even after 40 kilometers, though riders had never stopped breaking out from the peleton since race started. As the peleton kept its pace, Luke Mudgway from H&R Block Pro Cycling Team led the rabbit group of four who worked together quite well, with the gap of 1 minute 50 seconds. The gap narrowed, however, as the peleton started to chase with 30 kilometers to go,
CONQUEST Completes the Financing of Its Sustainable Infrastructure Portfolio24.9.2018 10:18 | Pressemelding
CONQUEST Asset Management (“CONQUEST”) announced it completed, on behalf of the Sustainable Infrastructure fund it manages, the financing of its solar photovoltaic assets portfolio. The transaction was closed with a major financial institution following a competitive selection process. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005404/en/ Photo Credit: Istock Prior to this transaction, CONQUEST had increased the size of its assets under management to circa 70MW as a result of 3 transactions closed in less than a year. This portfolio, located in the South of France, benefits from up to 20-year secured and inflation linked power purchase agreements from local incumbent utility EDF. “The financing market remains competitive across Western Europe for sustainable infrastructure. We are pleased with the outcome of this process and the quality of the project finance lenders and teams we managed to attract, which confirmed
L&T Technology Services (LTTS) wins USD 40 million Engineering Content Management (ECM) Deal in Europe24.9.2018 08:20 | Pressemelding
L&T Technology Services Limited (NSE: LTTS), a leading global pure-play engineering services company, today announced that it has won a multi-year deal to provide digital content management services to a leading technology company’s industrial products segment. The deal is expected to run for a period of 5 years with an aggregate revenue potential of USD 40 million, covering Engineering Content Management (ECM) programs in the US and European regions. LTTS will leverage centers in Europe, US & India while assuming complete ownership and talent to manage content for all current and future product suites for the customer. This would include technical design specifications, diagnostic solutions for service engineers and product training for customers & engineers, thereby supporting the entire ECM cycle from product conceptualization to developing digital content platforms. “With engineering content becoming one of the cornerstones of digital transformation, this deal win highlights LTTS’
Prima Solutions Expands Product Offering and Geographical Reach Through the Acquisition of ICOD Inc.24.9.2018 08:00 | Pressemelding
As part of its continuing growth strategy, Prima Solutions (Prima), the premier software platform for Property and Casualty insurers, has agreed to acquire ICOD Inc. (ICOD), the Canadian provider of software solutions for Life and Health insurance. Recognized as an established leader with its SN Assurance suite, ICOD offers a best-in class solution deliverable in SaaS or on premise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005019/en/ The transaction, which closed on September 20th, accelerates Prima’s expansion into the Life and Health insurance market which is still largely using legacy technologies. The ICOD acquisition offers many synergies including: complementing Prima’s existing product offering, diversifying its customer base and expanding the platform for rapid growth in both Europe and North America. Hugues Delannoy, Chairman of Prima Solutions, said: "This acquisition provides a unique opportunity to ac
GE Renewable Energy Launches Cypress Onshore Wind Platform, Designed to Grow, Adapt, Thrive and Lower the Cost of Electricity for Customers24.9.2018 07:00 | Pressemelding
GE Renewable Energy (NYSE:GE) today launched its new onshore turbine platform, named Cypress, and the next model from that platform, GE’s 5.3-158 turbine. The platform advances the proven technology of GE’s 2MW and 3MW fleets, which serves an installed base of nearly 20GW, while also utilizing architecture and innovations from the 4.8-158 turbine introduced in 2017. Cypress enables significant AEP improvements, increased efficiency in serviceability, improved logistics and siting potential, and ultimately more value for customers. It is designed to scale over time, enabling GE to offer a wider array of power ratings and hub heights to meet customer needs throughout the 5MW range. The platform also offers up to a 50 percent increase in AEP over the life of the platform versus GE’s 3MW turbines. It is the second major technology platform launch of the year for GE, which introduced the Haliade-X offshore turbine platform in March. This press release features multimedia. View the full rele